首页> 外文期刊>Clinical Biochemistry >A proposed stoichiometrical calibration procedure to achieve transferability of D-dimer measurements and to characterize the performance of different methods.
【24h】

A proposed stoichiometrical calibration procedure to achieve transferability of D-dimer measurements and to characterize the performance of different methods.

机译:提出了一种化学计量校准程序,以实现D-二聚体测量的可传递性并表征不同方法的性能。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: There is little transferability between D-dimer levels obtained by different reagents today. This makes it difficult to compare results from different clinical studies. OBJECTIVES: We give a comprehensive proposal for calibration of D-dimer assays. All crucial steps and underlying assumptions are made explicit. METHODS: The new approach is based on using a set of fibrinolysates of patient samples clotted and treated with tPA to obtain maximal conversion to D-dimers. Their expected maximal D-dimer concentrations are calculated stoichiometrically from their different fibrinogen values and the published molecular masses of fibrinogen and average D-dimer. The characteristics of five latex enhanced D-dimer immunoassays were also tested against early and late fibrin fragments using this procedure. These were produced by prolonged fibrinolysis of a set of patient samples of varying fibrinogen concentrations. RESULTS: These varied typically between methods and lysis times. One of the methods showing the highest yield irrespective of lysis time was used for calibration. A linear standard curve with zero intercept and R2 = 0.95 was obtained. CONCLUSION: Following this procedure will allow better transferability of D-dimer in future clinical trails.
机译:背景:当今不同试剂在D-二聚体水平之间的转移性很小。这使得很难比较不同临床研究的结果。目的:我们为D-二聚体测定的校准提供了全面的建议。所有关键步骤和基本假设均已明确。方法:新方法基于使用一组凝血酶和tPA处理的患者样品的纤维蛋白水解物,以获得最大的D-二聚体转化率。根据其不同的血纤蛋白原值和公布的血纤蛋白原和平均D-二聚体的分子质量,以化学计量计算其预期的最大D-二聚体浓度。还使用此程序针对早期和晚期血纤蛋白片段测试了五种乳胶增强D-二聚体免疫测定法的特征。这些是通过长时间对一组不同纤维蛋白原浓度的患者样品进行纤维蛋白溶解而产生的。结果:这些方法通常在方法和裂解时间之间变化。不管裂解时间如何,显示出最高产率的方法之一都用于校准。获得了具有零截距和R2 = 0.95的线性标准曲线。结论:遵循此程序将使D-二聚体在未来的临床试验中具有更好的转移性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号